Current Neuro-Oncology
Volume
27 Number 18
30 June 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 18, 30 June
Bagley SJ, Umemura Y, Mendez JS, Arrillaga-Romany I, Bielamowicz
KJ, Butowski N, Hutchins K, Kong XT, Odia Y, Sharma A, Weintraub
L, Koschmann C, Wen PY, Saratsis AM, Brundage T, Ramage SC,
Tarapore RS, Knowles T, Yang D, Allen JE, Cloughesy T.
Prognostic
Features of Recurrent Midline and H3 K27M-Mutant Glioma.
Cancers
(Basel). 2025 Jun 23;17(13):2107. doi:
10.3390/cancers17132107. PMID:
40647406. Observational study. ˍ
AI
Overview
Al-Mistarehi AH, Zaitoun KJ, Javed S, Xia Y, Hersh A, Ghaith AK,
Weber-Levine C, Jiang K, Khan M, Mendelson B, Ksabi N, Sciubba DM,
Gokaslan ZL, Jallo GI, Wolinsky JP, Theodore N, Lubelski D.
Survival and Functional Outcomes
Following Surgical Resection of Intramedullary Spinal Cord Tumors:
A Series of 253 Patients over 22 Years.
Cancers
(Basel). 2025 Jun 24;17(13):2112. doi:
10.3390/cancers17132112. PMID:
40647411. Observational study. ˍ
AI
Overview
Meulendijks TFC, Kaspers GJL, Ramaswamy V, Tsang DS, Laughlin S,
Bennett J, Nathan PC.
How long should
survivors of pediatric medulloblastoma and ependymoma be screened
for recurrence? A retrospective cohort study.
Int
J Cancer. 2025 Jun 23. doi:
10.1002/ijc.70016. PMID:
40548641. Observational study˰
ˍ
AI
Overview
Chen W, Wu D, Chen X.
Drug adverse
events associated with temozolomide administration: A real-world
pharmacovigilance study using the FAERS database from 2014 to
2024.
J
Oncol Pharm Pract. 2025 Jun 25:10781552251350618. doi:
10.1177/10781552251350618. PMID:
40566845. Observational study˰
ˍ
AI
Overview
Li J, Chang T, Zeng Y, Ma W, Liu J, Ren T, Niu X.
Clinical
Characteristics and Prognostic Outcomes of Spinal Cord Gliomas
with Intracranial Metastasis: An Integrated Analysis Based on
Individual Cases.
World
Neurosurg. 2025 Jun 25;200:124205. doi:
10.1016/j.wneu.2025.124205. PMID:
40578429. Observational study.
ˍ
AI
Overview
Vishnu AR, Damle NA, Haresh KP, Tripathi M, Priyanka GB.
68Ga-PSMA
PET/CT in a case of recurrent Glioblastoma.
Indian
J Nucl Med. 2025 Jun 27;40(2):115-116. doi:
10.4103/ijnm.ijnm_126_24. PMID:
40735748. Case report. ˍ
Breen WG, Dixon JG, Anderson SK, Sarkaria JN, Brown PD, Yan ES,
Kizilbash S, Galanis E, Anderson D, Tran D, Mazurczak M, Johnson
DR, Geoffroy FJ, Leinweber C, Laack NN.
Final
Report on NCCTG N0877 (Alliance): A Phase II Randomized,
Placebo-Controlled Trial of Chemoradiotherapy with or without
Dasatinib for Glioblastoma.
Neuro
Oncol. 2025 Jun 28:noaf156. doi:
10.1093/neuonc/noaf156. PMID:
40579995. Interventional study.
ˍ
Sferruzza G, Desingu K, Cubero Cruz A, Finocchiaro G.
Assessing
time-trend bias in glioblastoma prognosis over two decades of
clinical trials.
Neuro
Oncol. 2025 Jun 28:noaf158. doi:
10.1093/neuonc/noaf158. PMID:
40580109. Observational study˰
ˍ
AI
Overview